
Sign up to save your podcasts
Or
Layoffs in biopharma show no signs of slowing, with workforce reductions holding steady across the first two quarters of 2025.
In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson break down the latest layoff trends and how they compare to last year.
Tune in for a look at the numbers so far, the pace of biotech closures and how federal policy shifts are affecting the industry.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
3.8
88 ratings
Layoffs in biopharma show no signs of slowing, with workforce reductions holding steady across the first two quarters of 2025.
In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson break down the latest layoff trends and how they compare to last year.
Tune in for a look at the numbers so far, the pace of biotech closures and how federal policy shifts are affecting the industry.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
1,753 Listeners
381 Listeners
1,034 Listeners
991 Listeners
1,784 Listeners
375 Listeners
122 Listeners
318 Listeners
171 Listeners
876 Listeners
88 Listeners
29 Listeners
147 Listeners
10 Listeners
51 Listeners